Quantum Computing

搜索文档
11 Most Profitable Blue Chip Stocks to Buy Right Now
Insider Monkey· 2025-09-28 23:41
In this article, we will take a detailed look at 11 Most Profitable Blue Chip Stocks to Buy Right Now.Because of their strong finances, market dominance, steady profits, and dependable dividends, blue chip stocks continue to be a popular option for investors looking for stability in the face of turbulence. These large-cap corporations—many of which are part of the Dow Jones Industrial Average—frequently outperform during late-stage economic cycles or difficult times because they provide a combination of sca ...
Honeywell International Inc. (HON) Posts Strong Q2 Earnings, Advances Aerospace and Quantum Tech
Yahoo Finance· 2025-09-28 22:43
公司业务与战略 - 公司是一家多元化的全球技术和制造业领导者 在航空航天、工业自动化、能源解决方案和量子计算等新兴技术领域持续加强其地位[1] - 公司计划在2026年下半年分拆其航空航天业务 作为更广泛重组的一部分 以释放价值并专注于创新驱动的领域[3] - 公司正在推进其Solstice Advanced Materials部门的分拆计划 该计划得到了9月初发行的高级票据的支持[3] 财务表现 - 公司2025年第二季度每股收益为2.75美元 营收为103.5亿美元 超出市场预期[4] - 公司更新了其全年每股收益指引至10.45美元至10.65美元[4] 量子计算业务 - 公司在2025年9月为其量子计算子公司Quantinuum筹集了6亿美元股权融资 对该子公司的估值达到100亿美元[2] - 融资将加速Quantinuum下一代Helios系统的推出 并推动实现容错通用量子计算的进展[2] - 主要投资者包括NVIDIA、广达电脑和QED Investors[2] 航空航天业务 - 航空航天业务发展势头强劲 主要受强劲的国防需求和战略性供应链投资的推动[4] - 公司新推出的HON1600小型推力级飞机发动机针对无人军事行动 采用增材制造以实现更快生产和改善供应链弹性[4] 技术收购与产品 - 近期技术收购包括Li-ion Tamer和SparkMeter平台 加强了公司在建筑自动化和智能能源领域的产品供应[4] - 公司以强劲的股息和稳健的航空航天业务部门而闻名[1]
IonQ, Inc. (IONQ): A Bull Case Theory
Yahoo Finance· 2025-09-28 20:23
We came across a bullish thesis on IonQ, Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on IONQ. IonQ, Inc.'s share was trading at $66.81 as of September 18th. IonQ (IONQ) Climbs 33% as UK OKs $1-Billion Oxford Ionics Acquisition Photo by Anton Maksimov juvnsky on Unsplash IonQ (IONQ) is making a deliberate bet on the commercial viability of quantum computing within this decade, positioning itself to be among the first to scale the technology. The company ...
Meet the Monster Quantum Computing Stock That Continues to Crush Nvidia, Oracle, and Palantir
Yahoo Finance· 2025-09-28 18:00
Key Points Quantum computing stocks are beginning to outpace AI's largest players. D-Wave Quantum has witnessed a meteoric rise over the last year thanks to a frenzy of retail buying. D-Wave Quantum's momentum may be tempting to follow, but the company's progress remains limited and its valuation profile appears stretched. 10 stocks we like better than D-Wave Quantum › The artificial intelligence (AI) revolution has ignited tremendous investor interest about which technologies could drive the n ...
This Overlooked Dividend Stock Could Be a Quiet AI Winner
The Motley Fool· 2025-09-28 12:25
It's time for investors to pay attention to IBM stock.Artificial intelligence (AI) has driven huge returns for investors, particularly in a select few large-cap stocks. Every stock in the "Magnificent Seven" has benefited from the technology, and some smaller players have also earned outsized returns.Amid such gains, investors may forget that some of the oldest tech stocks in existence have made notable pivots into AI. Knowing that, it might be time to pay particular attention to the comeback in Internation ...
Prediction: This Quantum-AI Stock Could Be the Nvidia of the 2030s
The Motley Fool· 2025-09-28 10:30
IonQ's trapped-ion approach offers a significant advantage on accuracy over most competitors' quantum computers.Nvidia (NVDA 0.27%) has been one of the top-performing stocks over the past decade. If you invested $10,000 in the stock a decade ago, you'd have a position worth $3 million now. It's success stories like that that keep ambitious investors hunting for the less known stocks today that have the potential to provide similar gains from here.Artificial intelligence (AI) is a massive investment theme ri ...
Wall Street keeps cool as casino crowd cashes out of risky bets
BusinessLine· 2025-09-28 10:08
By most measures, markets remain on strong footing. Economic data continues to surprise to the upside. The Federal Reserve has extended a fresh lifeline to Wall Street. Stocks are close to recent highs.But beneath that surface, there are signs of a shift.Risk-loving day traders are stepping back from the market’s frothiest corners — bets that soared through the summer on little more than momentum and hype. In recent days, money has flowed out of exchange-traded funds focused on frontier technologies and hig ...
Moody’s Lowers the Credit Rating of Otter Tail Corporation (OTTR) ’s Utility Subsidiary, Otter Tail Power Company
Yahoo Finance· 2025-09-27 15:40
Otter Tail Corporation (NASDAQ:OTTR) is one of the 13 Best Diversified Stocks to Buy According to Hedge Funds. Moody’s Lowers the Credit Rating of Otter Tail Corporation (OTTR) ’s Utility Subsidiary, Otter Tail Power Company On August 29, 2025, Moody’s lowered the credit rating of Otter Tail Corporation (NASDAQ:OTTR)’s utility subsidiary, Otter Tail Power Company. The credit rating firm cited the company’s higher spending on projects and increased borrowing. Yet the outlook remains stable. This follows t ...
Rosen Law Firm Initiates Investigating Potential Breaches of Fiduciary Duty by Danaher Corporation (DHR)
Yahoo Finance· 2025-09-27 15:06
With significant upside potential, Danaher Corporation (NYSE:DHR) secures a spot on our list of the 13 Best Diversified Stocks to Buy According to Hedge Funds. Rosen Law Firm Initiates Investigating Potential Breaches of Fiduciary Duty by Danaher Corporation (DHR) On September 20, 2025, Rosen Law Firm announced that it is investigating potential breaches of fiduciary duty by Danaher Corporation (NYSE:DHR)’s directors and officers. Accordingly, the law firm encouraged shareholders to consider legal option ...
Johnson & Johnson (JNJ) to Withdraw the LINC Reflux Management System from Markets Outside the U.S.
Yahoo Finance· 2025-09-27 14:44
公司业务动态 - 强生公司宣布将于2026年3月底前因商业原因在美国以外市场撤下LINC胃食管反流管理系统[2] - 该磁性环装置在美国市场将继续供应 用于治疗慢性胃食管反流疾病[2] 投资机构观点 - 古根海姆将强生目标价从167美元上调至206美元 涨幅达23%[3] - 机构看好公司2025年营收增长 尽管Stelara药物失去专利独占权[3] - 新推出的膀胱癌药物Inlexzo(TAR-200)和TAR-210预计峰值销售额将超过60亿美元[3] 公司业务概况 - 强生在全球范围内专注于医疗保健产品的研发、制造和销售[4] - 业务涵盖制药、医疗器械和消费者健康三大领域[4] - 被列为最佳多元化股票之一[1][4] 行业比较 - 人工智能股票被认为具有更大上涨潜力和更低下行风险[5] - 部分AI股票可能从特朗普时代关税和回流趋势中获益[5]